Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/1995
06/14/1995EP0657463A1 Phospholipid derivative and vesicle comprising the same
06/14/1995EP0657170A1 Products for the application of high initial doses of cetrorelix and preparation of a combined package for use in treating diseases
06/14/1995EP0657164A1 Pharmaceutical compositions containing staurosphorine derivatives
06/14/1995EP0657161A1 Pharmaceutical granulate containing steroids
06/14/1995EP0656883A1 Cationic lipids
06/14/1995EP0656881A1 Ester and combinations of an organic nitrate and a salicylate
06/14/1995EP0656792A1 A dressing for dosing one or more medicaments.
06/14/1995EP0656786A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
06/14/1995EP0656779A1 Submicron emulsions as ocular drug delivery vehicles
06/14/1995EP0656777A1 Ready-to-inject azosemide solutions.
06/14/1995EP0656775A1 Sustained release tablets containing bupropion
06/14/1995EP0656771A1 Printed transdermal drug delivery device
06/14/1995DE4405296C1 Transdermal therapeutic equipment-production method
06/14/1995DE4402867C1 Liposome(s) contg. encapsulated protein for pharmaceutical or cosmetic use
06/14/1995DE4342232A1 Solid prostaglandin E1 formulations
06/14/1995CN1103589A Plaster for treating respiratory system diseases
06/14/1995CN1103587A Pills for leukodermia
06/14/1995CN1103586A Preparing method for fluid infusion to relieving pain
06/14/1995CN1103585A Plaster for activating collaterals to relieve pain
06/14/1995CA2136118A1 Pharmaceutical composition for controlled release
06/14/1995CA2111320A1 Pharmaceutical granulate
06/13/1995US5424471 Crystalline amifostine compositions and methods of the preparation and use of same
06/13/1995US5424469 Process for preparing polyglycerol fatty acid ester mixtures and use in cosmetic, pharmeceutical and chemical preparations
06/13/1995US5424400 Senescent cell derived inhibitors of DNA synthesis
06/13/1995US5424301 Cognition activators
06/13/1995US5424298 Topical powder compositions containing a cyclic AMP derivative
06/13/1995US5424289 Solid formulations of therapeutic proteins for gastrointestinal delivery
06/13/1995US5424288 Prolonging time therapeutic agent remains in tumor
06/13/1995US5424208 Contacting connective tissue containing viable cells with collagenase and chymopapain to hydrolyze the connective tissue
06/13/1995US5424078 Aqueous ophthalmic formulations and methods for preserving same
06/13/1995US5424077 Co-micronized bicarbonate salt compositions
06/13/1995US5424076 Sustained release
06/13/1995US5424075 Delivery system for enhanced onset and increased potency
06/13/1995US5424073 Anticancer agents
06/13/1995US5424067 Water-immiscible oily phase, emulsifying system, and aqueous antigen; nontoxic
06/13/1995US5424064 Treatment of reflux esophagitis using dimethylpolysiloxane
06/13/1995US5423778 System and method for transplantation of cells
06/13/1995US5423739 Device and method for iontophoretic drug delivery
06/13/1995EP0724449A4 Preservative for pharmaceutical products
06/13/1995CA1335924C Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus
06/10/1995CA2137426A1 Diffusion-osmotic controlled drug-release pharmaceutical compositions and process for preparing same
06/08/1995WO1995015343A1 POLY-β-1→4-N-ACETYLGLUCOSAMINE
06/08/1995WO1995015169A1 Use of dimeticone for treating aphthae and stomatitis
06/08/1995WO1995015162A1 Tablet or capsule containing a stable type 1 ranitidine hydrochloride
06/08/1995WO1995015158A1 Pflaster containing an active substance
06/08/1995WO1995015157A1 Viracidal, bactericidal and spermicidal vaginal suppository
06/08/1995WO1995015156A1 Device for effecting the controlled release of active substances
06/08/1995WO1995015155A1 Taste masked composition containing a drug/polymer complex
06/08/1995WO1995015154A1 A medicament for the treatment of metastases
06/08/1995WO1995015153A1 Process for enhancing the stability of liposomal suspensions containing hydrophilic active agents
06/08/1995WO1995015152A1 External preparation
06/08/1995WO1995015151A1 Aerosol drug formulations for use with non-cfc propellants
06/08/1995WO1995015143A2 Stable multiple x/o/y emulsion
06/08/1995WO1995015137A1 Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
06/08/1995WO1995015118A1 Gas microspheres for topical and subcutaneous application
06/08/1995WO1995013071A3 Treatment of immunoregulatory disorders
06/08/1995DE4421433C1 Transdermal therapeutic system for treatment of, e.g., hypertension
06/08/1995DE4341548A1 Rod of detachable tablets for making drink
06/08/1995DE4341114A1 Emulsions comprising non-aqueous phase dispersed in oil phase
06/08/1995CA2177973A1 Process for enhancing the stability of liposomal suspensions containing hydrophilic active agents
06/08/1995CA2177721A1 Taste masked composition containing a drug/polymer complex
06/08/1995CA2177713A1 Gas microspheres for topical and subcutaneous application
06/07/1995EP0656426A2 New Method of making crystalline sugar and products resulting therefrom
06/07/1995EP0656213A1 Treatment of conditions and disease
06/07/1995EP0656212A1 Liquid compositions containing cyclosporin and process for their preparation
06/07/1995EP0656211A1 Stable lyophilized thiotepa composition
06/07/1995EP0656207A1 Non-chlorofluorocarbon aerosol formulations
06/07/1995EP0656206A1 Non-chlorofluorocarbon aerosol formulations
06/07/1995EP0656205A1 Non-chloroflurocarbon aerosol formulations
06/07/1995EP0656204A1 Controlled release pharmaceutical tablet having lenticular form
06/07/1995EP0656203A1 Injectable microfoam containing a sclerosing agent
06/07/1995EP0656026A1 Polyarylates containing derivatives of the natural amino acid l-tyrosine
06/07/1995EP0656021A1 Use of water-soluble or water-dispersible polyurethanes as auxiliary agents in cosmetic and pharmaceutical preparations and polyurethanes containing polylactic acid polyols incorporated by polymerization.
06/07/1995EP0655946A1 Utilization of a transacylation reaction between an esterified polysaccharide and a polyaminated or polyhydroxylated substance for fabricating microparticles, microparticles thus obtained, methods and compositions containing them
06/07/1995EP0655921A1 Novel glucan preparation
06/07/1995EP0655918A1 Treatment of cancer with azt and alkylating or intercalating agents
06/07/1995EP0655917A1 Crystalline amifostine compositions and methods for the preparation and use of same
06/07/1995EP0655916A1 Transdermal application agent containing 3-keto-desogestrel
06/07/1995EP0655914A1 Novel compositions
06/07/1995EP0655911A1 Ophthalmological preparation
06/07/1995EP0655910A1 Use of pouch for implantation of living cells
06/07/1995EP0655900A1 Foam laminate transdermal patch
06/07/1995EP0630286A4 Oil-in-water emulsions of positively charged particles.
06/07/1995EP0524968B1 Heterovesicular liposomes
06/07/1995CN2199788Y Hydrophobic high-molecular material tube constant speed releasing medicament type
06/07/1995CN1103316A Cyclodextrin and polymer-based drug delivery system
06/07/1995CN1103308A Ointment for improvement of blood circulation and drawing out pus
06/07/1995CN1103306A "Qianglifengxin" medical pill
06/07/1995CN1103305A Diabetes powder and its preparing method
06/07/1995CN1103304A Healthy therapy medicine for Ji acupoints
06/07/1995CN1103303A Sexual disinfecting aerosol for man
06/07/1995CN1103302A Hypolipemic and heart tonifying capsule and preparing process thereof
06/07/1995CN1103292A Analgin nasal drops
06/07/1995CN1103291A Preparation for skin and mucous membrane
06/07/1995CN1103290A Pharmaceutical preparation
06/07/1995CN1103289A Opioid formulations having extended controlled release
06/07/1995CN1103288A Local anaesthetic and its preparing method
06/06/1995US5422424 Antibiotic cryptdin peptides and methods of their use
06/06/1995US5422376 Synthetic viscoelastic material for ophthalmic applications
06/06/1995US5422371 Contacting a cell with a fatty acid or fatty alcohol to prevent reduction of testosterone to 5a-dihydrotestosterone
1 ... 2737 2738 2739 2740 2741 2742 2743 2744 2745 2746 2747 2748 2749 2750 2751 2752 2753 2754 2755 2756 2757 ... 2991